Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA) — Cash Flow Reinvestment Rate
Latest as of September 2025:
0.00x
Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA) has a Cash Flow Reinvestment Rate of 0.00x as of September 2025, reinvesting $4.00 (capex $4.00 ) from operating cash flow of $137.91K. See DMAA FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
0.00x
(Capex + Investments) / Operating CF
Total Reinvested
$4.00
Capex + Investments
Operating Cash Flow
$137.91K
USD
Capital Expenditures
$4.00
USD
Annual Cash Flow Reinvestment Rate for Drugs Made In America Acquisition Corp. Ordinary Shares (None–None)
Year-by-year capital reinvestment analysis for Drugs Made In America Acquisition Corp. Ordinary Shares. See how financially flexible is Drugs Made In America Acquisition Corp. to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow